Market Overview

Global Mice Model Market worth 1,370.5 million USD by 2023


LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- According to the latest publication from Meticulous Research®, the global mice model market is expected to reach USD 1,370.5 million by 2023, at a CAGR of 7.2% from 2018. This market is majorly driven by "continuing modification in mice model for cancers, immune diseases, and rare diseases; increasing devouring of personalized medicine propelling demand for humanized mice model; rising grants and investments for biological research; rising pharmaceutical R&D activities; and increasing focus of International Mouse Phenotyping Consortium (IMPC) and International Knockout Mouse Consortium (IKMC) on the development of embryonic stem cells as well as knockout and mutant mice."

Request Sample Report:

CRISPR-Cas9 gene editing technology with its ease to perform, versatility, and high efficiency has significantly improved the production of desired modified alleles. This technology has enabled rapid production of knockout, conditional alleles or mice carrying single point mutations, which mimic those in human patients, in only several weeks. Thus, this technology provides significant potential in near future.

The mice model market is mainly segmented based on type, services, therapeutic area, technology, mice care products, end user, and geography. On the basis of type, inbred mice segment is expected to continue to dominate the market during the forecast period, mainly attributed to "high level of genetic stability over long period of time, easy breeding, and being more defined in nature compared to other types of mice".

Academic and research institutes will continue to be the leading adopters of mice model market in projected period. However, demand from Contract Research Organizations (CROs) is expected to grow significantly with the growing demand from pharmaceutical and biotechnology companies to outsource development of their biologics and production activities.

Asia-Pacific region is expected to be the fastest-growing market, mainly due to "accelerated economic growth of many countries in the region, growing biomedical & personalized research areas, and rising focus on the regenerative medicine in order to understand the translational research field".

The key players operating in this market are Charles River Laboratories International, Inc., The Jackson Laboratory, Laboratory Corporation of America Holdings, Horizon Discovery Group plc, Trans Genic Inc., genOway, Taconic Biosciences, Inc., Envigo, JANVIER LABS, Ingenious Targeting Laboratory, and Harbour Antibodies BV among others.

Browse in-depth report on:

Contact Info:
Viren Shrivastava
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)

Primary Logo

View Comments and Join the Discussion!